Titre :

Use of magnesium sulfate before 32?weeks of gestation: a european population-based cohort study

Auteur(s) :

Wolf, H T. [Auteur]
Huusom, L. [Auteur]
Weber, T. [Auteur]
Piedvache, Aurelie [Auteur]
Schmidt, S. [Auteur]
Norman, Mikael [Auteur]
Zeitlin, Jennifer [Auteur]

Titre de la revue :

BMJ open

Nom court de la revue :

BMJ Open

Numéro :

7

Pagination :

e013952

Date de publication :

2017-01-27

ISSN :

2044-6055

Mot(s)-clé(s) en anglais :

PREVENTIVE MEDICINE

Discipline(s) HAL :

Sciences du Vivant [q-bio]

Résumé en anglais : [en]

The use of magnesium sulfate (MgSO44 We used data from the European Perinatal Intensive Care in Europe (EPICE) population-based cohort study of births before 32 weeks of gestation in 19 regions in 11 European countries. ...
Lire la suite >The use of magnesium sulfate (MgSO44 We used data from the European Perinatal Intensive Care in Europe (EPICE) population-based cohort study of births before 32 weeks of gestation in 19 regions in 11 European countries. Data were collected from April 2011 to September 2012 from medical records and questionnaires. The study population comprised 720 women with severe pre-eclampsia, eclampsia or HELLP and 3658 without pre-eclampsia delivering from 24 to 31 weeks of gestation in 119 maternity units with 20 or more very preterm deliveries per year. Among women with severe pre-eclampsia, eclampsia or HELLP, 255 (35.4%) received MgSO44444444 Severe pre-eclampsia, eclampsia or HELLP are not treated with MgSO444Lire moins >

Langue :

Anglais

Audience :

Internationale

Vulgarisation :

Non

Établissement(s) :

CHU Lille
Université de Lille

Collections :

• METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694

Date de dépôt :

2019-12-09T18:16:01Z